ECOPPIA SCIENTIFIC LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156.4 ILa | +0.39% |
|
+2.09% | -2.31% |
| Mar. 31 | Ecoppia Scientific Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Ecoppia Scientific Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 409.9 | 110.6 | 31.14 | 43.46 |
| Enterprise Value (EV) 1 | 310.7 | 24.62 | -30.66 | -7.041 |
| P/E ratio | -8.23 x | -8.39 x | -1.45 x | -3.2 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 135 x | 18.7 x | 7.4 x | 14.4 x |
| EV / Revenue | 102 x | 4.17 x | -7.29 x | -2.33 x |
| EV / EBITDA | -35.4 x | -1.96 x | 1.8 x | 0.47 x |
| EV / FCF | -50,856,839 x | -2,830,685 x | 1,896,566 x | 945,421 x |
| FCF Yield | -0% | -0% | 0% | 0% |
| Price to Book | 3.84 x | 1.16 x | 0.41 x | 0.71 x |
| Nbr of stocks (in thousands) | 97,716 | 97,716 | 98,047 | 98,051 |
| Reference price 2 | 4.195 | 1.132 | 0.3176 | 0.4433 |
| Announcement Date | 3/24/21 | 3/31/22 | 4/1/23 | 3/31/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.934 | 8.046 | 3.032 | 5.905 | 4.208 | 3.024 |
| EBITDA 1 | -3.285 | -3.151 | -8.785 | -12.59 | -17.02 | -14.9 |
| EBIT 1 | -3.619 | -3.488 | -9.121 | -12.8 | -17.74 | -15.72 |
| Operating Margin | -73.35% | -43.35% | -300.82% | -216.78% | -421.51% | -519.78% |
| Earnings before Tax (EBT) 1 | -3.815 | -3.455 | -18.87 | -13.15 | -21.47 | -13.62 |
| Net income 1 | -3.736 | -3.707 | -18.89 | -13.18 | -21.49 | -13.63 |
| Net margin | -75.72% | -46.07% | -622.96% | -223.2% | -510.6% | -450.79% |
| EPS 2 | -0.1161 | -0.1229 | -0.5100 | -0.1350 | -0.2191 | -0.1386 |
| Free Cash Flow | - | -2.833 | -6.109 | -8.696 | -16.17 | -7.448 |
| FCF margin | - | -35.21% | -201.49% | -147.27% | -384.17% | -246.29% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 11/19/20 | 11/19/20 | 3/24/21 | 3/31/22 | 4/1/23 | 3/31/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 5.61 | 0.72 | 99.2 | 86 | 61.8 | 50.5 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -2.83 | -6.11 | -8.7 | -16.2 | -7.45 |
| ROE (net income / shareholders' equity) | - | -40% | -33.1% | -13% | -25.2% | -20% |
| ROA (Net income/ Total Assets) | - | -16.9% | -9.2% | -7.57% | -12.3% | -13.5% |
| Assets 1 | - | 21.88 | 205.2 | 174.1 | 174.8 | 100.6 |
| Book Value Per Share 2 | 0.2700 | 0.0800 | 1.090 | 0.9800 | 0.7700 | 0.6300 |
| Cash Flow per Share 2 | 0.1400 | 0.0400 | 1.020 | 0.8800 | 0.1800 | 0.0400 |
| Capex 1 | 0.15 | 0.24 | 0.31 | 1.03 | 2.16 | 0.29 |
| Capex / Sales | 3.1% | 2.93% | 10.26% | 17.41% | 51.28% | 9.62% |
| Announcement Date | 11/19/20 | 11/19/20 | 3/24/21 | 3/31/22 | 4/1/23 | 3/31/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -2.31% | 41.14M | |
| +12.94% | 109B | |
| +0.91% | 30.23B | |
| +12.31% | 22.34B | |
| -11.83% | 18.66B | |
| -8.62% | 16.99B | |
| +15.54% | 16.24B | |
| -5.91% | 12.07B | |
| +1.93% | 10.99B | |
| -15.91% | 8.36B |
- Stock Market
- Equities
- ECPA-M Stock
- Financials Ecoppia Scientific Ltd
